Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr3-octreotide versusF-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy

Author: Virgolini I.   Patri P.   Novotny C.   Traub T.   Leimer M.   Füger B.   Li S.   Angelberger P.   Raderer M.   Wogritsch S.   Kurtaran A.   Kletter K.   Dudczak R.  

Publisher: Springer Publishing Company

ISSN: 0923-7534

Source: Annals of Oncology, Vol.12, Iss.2, 2001-02, pp. : 41-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content